Brief: Aurobindo Pharma Says Eugia Pharma Receives USFDA Approval For Everolimus Tablets
26/02/2026 06:31
Feb 26 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: AUROBINDO PHARMA - EUGIA PHARMA RECEIVES USFDA APPROVAL FOR EVEROLIMUS TABLETS AUROBINDO PHARMA - LAUNCH EXPECTED IN Q1FY27 Source text: ID:nNSEbRhvzb Further company coverage: ARBN.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11